Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE: EMH )

N/A UNCHANGED
Last Price Updated: 1:23 PM EST, Nov 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.0050 (867,000)
Ask (Size) 0.8000 (17,000)
Prev. Close 0.0350
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile

Performance

More News

Read More
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
Via Newsfile
Topics Derivatives
Exposures Derivatives
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
Via Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Via Newsfile
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
Via Newsfile
Topics Cannabis
Exposures Cannabis
Rainbow Washing: How Insincere Branding Tarnishes Pride And Similar Celebrations Of Communities
Via Benzinga
A Brief Overview: How Cannabis And LGBTQ Rights Reform Have Intertwined Through The Decades
Via Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
Via Newsfile
Topics Derivatives
Exposures Derivatives
Emerald Health Therapeutics Sells Patents to FlowerPod
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
Via Benzinga
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Via Newsfile
Topics Cannabis Supply Chain
Exposures COVID-19 Cannabis Supply Chain
Emerald Health's Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis Vaporizer
Via Benzinga
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Via Newsfile
Topics Cannabis Supply Chain
Exposures COVID-19 Cannabis Supply Chain
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Via Newsfile
Topics Cannabis Intellectual Property Product Recall
Exposures COVID-19 Cannabis Intellectual Property
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Comments on Board Resignation
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Hires VP Sales & Marketing
Via Newsfile
Topics Cannabis Supply Chain
Exposures COVID-19 Cannabis Supply Chain
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Launches Fuse(TM) Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage
Via Newsfile
Topics Cannabis
Exposures Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.